Clinical trial Recruiting at 1 site Observational Ages 18 and up

Lateral, Anterior, Medial (LAM) femoral cutaneous block for thigh donor-site pain

Official title: The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA

Run by University of Washington · NCT07221903 · Data updated 2026-11-12

This tries to see if a LAM nerve block can numb the anterolateral thigh and reduce donor-site pain without weakening leg muscles in adults having split-thickness skin grafts.

More Regional Anesthesia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 4, 2025
Trial IDNCT07221903 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) scheduled for split-thickness skin grafting with a thigh donor site whose care team plans to use a LAM nerve block and who can report sensation changes are ideal candidates.

Probably not a fit

Patients with preexisting sensory or motor deficits in the femoral distribution, large burns (TBSA ≥20%), prolonged surgeries, contraindications to local anesthetics, inability to communicate, pregnancy, or incarceration are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will map the skin sensation changes after administering a LAM nerve block in adults who are having split-thickness skin grafts with a thigh donor site. The observational case series will record the size and consistency of areas with decreased sensation after the block and document any changes in motor function. Patients are enrolled when their surgical team requests a LAM block and exclusions include preexisting femoral nerve deficits, pregnancy, TBSA ≥20%, severe polytrauma, or inability to report sensation. All procedures take place at Harborview Medical Center and no experimental drugs are given beyond the local anesthetic used for the block.

Why it matters

Potential benefit: If successful, the LAM block could reduce donor-site pain while preserving leg motor function after split-thickness skin grafting.

How similar studies have gone: The LAM block is relatively new and evidence is limited to early reports and case series, while broader blocks like the fascia iliaca are established but commonly cause motor weakness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18 years or older
2. Scheduled surgery for STSG w/ donor site coming from thigh
3. Care team requests LAM nerve block
4. Anticipated postop pain in the cutaneous areas of anterior and lateral thigh

   Exclusion Criteria:
5. Inability to communicate sensation or motor changes in their body
6. Preexisting sensory or motor deficits in the femoral nerve distribution
7. Contraindication to the medication used or a peripheral nerve block, such as allergy to amide local anesthetics, severe liver dysfunction, injection site infection etc
8. Pregnancy
9. Prisoners
10. Non-English Speaking/reading
11. Surgeries with anticipated or actual duration of 6 hours or longer
12. TBSA 20% or greater
13. Severe distracting injuries/polytrauma (e.g., large or significant bone fractures)

Where it's running

  • Harborview Medical Center
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Dorothy Wang, MD, MHA — University of Washington
  • Study coordinator: Adrienne James
  • Email: ajames1@uw.edu
  • Phone: 206-744-4634

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.